Essential Share Care Agreements (ESCA's)
Essential Shared Care Agreements (ESCAs) are written agreements between specialist services and general practitioners, and allow care, specifically prescribing, to be safely shared between them. They are individual to a specific drug, and detail who is responsible for what aspect of care, and when early referral is required back to specialist services. They allow the seamless transfer of prescribing responsibility from the specialist services to general practice.
All ESCAs are agreed by the Trust's Medicines Optimisation Committee whose membership includes representatives from the local Primary Care Trusts. ESCAs are normally developed for all drugs, which are either specialist in nature, or that have specific monitoring requirements, e.g. a blood test is required at regular intervals.
It has been agreed by the Medicines Optimisation Committee, that where general practice refuses to enter into a shared care agreement for a drug that has been pronounced on by NICE as appropriate for shared care, the clinician should complete the Proforma for ESCA Refused by General Practice in order that the Trust can charge the CCG appropriately.
In order that we do not charge the CCG inappropriately it is essential that, when the service is no longer providing the prescription, the clinician informs us by completing the ESCA Refused by General Practice - Service no longer prescribing as soon as possible.
Agreements - South Staffordshire & Shropshire CCG Locality
E051 Antipsychotic Depot & LAIs
E093 Atypical Antipsychotic in Learning Disabilities
E094 ADHD in Children & Adolescents
E097 Fluoxetine in Children & Adolescents
Agreements - Shropshire/Telford and Wrekin Prescribing Information Documents (PIDs) & ESCAs
E101 ADHD in Children and Younger People
E070 Disulfiram
Shropcom / Prison ESCA
Community Children's Nurses (CCNs) Administration Agreements
E079 ESCA Cytarabine March 2018 V3
E080 Meropenem for Administration in the Community
E081 Gentamicin for Administration in the Community
E082 Tobramycin for Administration in the Community
E083 Piperacillin with Tazobactam for Administration in the Community
E084 Lenograstim for Administration in the Community
E085 Methotrexate for Administration in the Community
E086 Vancomycin for Administration in the Community
E087 Dalteparin for Administration in the Community
E088 Aciclovir for Administration in the Community
E091 Teicoplanin for Administration in the Community
CCN ESCA Standing Operating Procedure
Refusal of Repeat Prescribing by GP- Letter Templates
Prescribing Guidelines
Guidelines for Antipsychotics in Dementia - Shrops and T&W
Guidelines for Antipsychotics in Dementia - South Staffs Locality
Prescribing Guidelines - Melatonin
Lithium Guidelines and Monitoring Booklets
Guidelines for the Monitoring of Lithium
When initiating a patient on Lithium please ensure that you provide a Lithium Monitoring Booklet to the patient/service user/carer and discuss with them the monitoring requirements. Copies of the booklet can be obtained by completing the Lithium Pack Order Form
